Medicare Enrolled
Dr. Hartwig Boepple, M.D.
Pulmonary Disease · Williamsville, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Boepple from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Boepple?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Boepple
Dr. Hartwig Boepple is a pulmonary disease specialist in Williamsville, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Boepple performed 688 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Boepple received a total of $15,895 from 59 pharmaceutical and/or device companies across 855 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Boepple is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 688 Medicare services
$15,895 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗688
Medicare services
Bottom 48% in NY for pulmonary disease
Not available
Unique patients (not deduplicated)
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
290 | $87 | $200 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
145 | $26 | $137 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
95 | $40 | $110 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
88 | $37 | $118 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $119 | $395 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
21 | $18 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $53 | $158 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,895
Total received (2018-2024)
Avg $2,271/year across 7 years
Top 13% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
855
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,513
2023
$2,586
2022
$2,418
2021
$2,897
2020
$1,504
2019
$2,035
2018
$1,942
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$473
GlaxoSmithKline, LLC.
$366
GENZYME CORPORATION
$330
Boehringer Ingelheim Pharmaceuticals, Inc.
$173
Mylan Specialty L.P.
$153
Mallinckrodt Hospital Products Inc.
$121
Grifols USA, LLC
$107
Takeda Pharmaceuticals U.S.A., Inc.
$99
Regeneron Healthcare Solutions, Inc.
$87
Electromed, Inc.
$85
Insmed, Inc.
$75
Actelion Pharmaceuticals US, Inc.
$71
3B Medical, Inc.
$60
Amgen Inc.
$59
Merck Sharp & Dohme LLC
$49
Philips North America LLC
$41
Inspire Medical Systems, Inc.
$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Exact Sciences Corporation
$19
INOGEN, INC.
$18
ANI Pharmaceuticals, Inc.
$17
PFIZER INC.
$15
Axsome Therapeutics, Inc.
$15
Top 3 companies account for 46.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,826
GlaxoSmithKline, LLC.
$2,495
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,358
Actelion Pharmaceuticals US, Inc.
$1,236
GENZYME CORPORATION
$1,198
Mallinckrodt Hospital Products Inc.
$530
Electromed, Inc.
$482
Mylan Specialty L.P.
$446
Regeneron Healthcare Solutions, Inc.
$406
Insmed, Inc.
$405
Grifols USA, LLC
$399
Bayer HealthCare Pharmaceuticals Inc.
$364
JAZZ PHARMACEUTICALS INC.
$290
Gilead Sciences, Inc.
$249
Amgen Inc.
$237
Takeda Pharmaceuticals U.S.A., Inc.
$235
United Therapeutics Corporation
$221
Teva Pharmaceuticals USA, Inc.
$219
PFIZER INC.
$167
Philips Electronics North America Corporation
$165
Lilly USA, LLC
$150
BIOTRONIK INC.
$125
Sunovion Pharmaceuticals Inc.
$115
Jazz Pharmaceuticals Inc.
$107
Inogen, Inc.
$98
Bayer Healthcare Pharmaceuticals Inc.
$87
Genentech USA, Inc.
$85
Circassia Pharmaceuticals Inc
$84
Merck Sharp & Dohme Corporation
$65
Mallinckrodt LLC
$65
Merck Sharp & Dohme LLC
$64
Axsome Therapeutics, Inc.
$63
3B Medical, Inc.
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$56
Kowa Pharmaceuticals America, Inc.
$54
Paratek Pharmaceuticals, Inc.
$52
Novo Nordisk Inc
$52
Advanced Respiratory, Inc
$47
Alexion Pharmaceuticals, Inc.
$45
Fisher & Paykel Healthcare Inc
$43
Philips North America LLC
$41
Inspire Medical Systems, Inc.
$40
PORTOLA PHARMACEUTICALS, INC.
$35
Shire North American Group Inc
$34
Resmed Corp
$31
ADVANCED RESPIRATORY, INC
$28
E.R. Squibb & Sons, L.L.C.
$25
Vanda Pharmaceuticals Inc.
$24
Pulmonx Corporation
$24
ABBVIE INC.
$21
AbbVie Inc.
$21
Exact Sciences Corporation
$19
INOGEN, INC.
$18
ANI Pharmaceuticals, Inc.
$17
kaleo, Inc.
$17
Baxter Healthcare
$15
PORTOLA PHARMACEUTICALS, LLC
$15
Amarin Pharma Inc.
$13
Allergan Inc.
$12
Top 3 companies account for 42.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AUVI-Q · Adempas · Aimovig · AirDuo Digihaler · Andexxa · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · Cologuard Collection Kit · DIFICID · DUAKLIR PRESSAIR · DUPIXENT · ELIQUIS · EMGALITY · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · GLASSIA · HETLIOZ · Hillrom - Life 2000 Ventilation System · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · JARDIANCE · LONHALA MAGNAIR · LUNA · Life 2000 Ventilation System · Livalo · MOUNJARO · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Otezla · PANZYGA · PAXLOVID · POMPE - DISEASE · PREVNAR 20 · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QULIPTA · QVAR · REMODULIN · Repatha · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UBRELVY · UPTRAVI · UTIBRON · Utibron · Vascepa · WINREVAIR · Wegovy · Wellcentive Undiv · XIFAXAN · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZENPEP · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
26
County median income
$71,175
Nearest hospital to ZIP centroid (approximate)
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
5.6 mi
5.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Boepple is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Boepple experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Boepple performed 290 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Boepple receive payments from pharmaceutical companies?
Yes. Dr. Boepple received a total of $15,895 from 59 companies across 855 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Boepple's costs compare to other pulmonary diseases in Williamsville?
Dr. Boepple's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Boepple) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Williamsville
Browse pulmonary diseases in Williamsville ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology